Yash Chemex is a chemical trading and manufacturing company that supplies fine and specialty chemicals, dyes, and intermediaries to industrial clients, primarily through its subsidiary Yasons Chemex Care.
The company lacks a sustainable competitive advantage, operating in a highly fragmented and commoditized trading market. This is evidenced by razor-thin net margins averaging below 3% and volatile profitability that dipped into losses at the standalone level in FY24.
Management has focused on maintaining a majority stake in its subsidiary Yasons Chemex Care, which recently went public. While they reinvest profits to build reserves, the returns on capital are mediocre, and the negative cash conversion suggests capital is frequently tied up in working capital rather than generating free cash flow.
Five years out, the capital loss resulted from a lethal combination of working capital mismanagement and the inherent fragility of a low-margin trading model. The negative cash conversion observed in earlier filings eventually starved the business of liquidity, forcing expensive debt to cover operational gaps. As a mere middleman in a fragmented commodity market, the company was unable to pass on rising costs, causing the already thin net margins to evaporate entirely. The complex web of related-party transactions and promoter-heavy governance ultimately prioritized family-controlled entities over minority shareholders, leaving the public with a hollowed-out shell of a business that failed to generate any real free cash flow.
RichFakir rates Yash Chemex Ltd's business quality as poor — 33/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Yash Chemex Ltd is trading about 75% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Yash Chemex Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Yash Chemex Ltd's fair value is about ₹28 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →